| GSK PLC SP. ADR/2 NEW |
| USA |
| Gesundheit |
| US37733W2044 / A3DMHS |
| GS70 (Frankfurt) / GSK (NYSE) |
| FRA:GS70, ETR:GS70, GS70:GR, NYSE:GSK |
| - |
| https://www.gsk.com/ |
|
GSK plc Sponsored ADR represents shares in GSK plc, a global healthcare company headquartered in Middlesex, United Kingdom, and founded in 1715. The company focuses on the research, development, and manufacture of pharmaceutical medicines, vaccines, ..
>Volltext.. |
| 96464.54 Mio. EUR |
| 112653.17 Mio. EUR |
| 37350.47 Mio. EUR |
| 12445.62 Mio. EUR |
| 6525.23 Mio. EUR |
| 3.22 EUR |
| 20647.99 Mio. EUR |
| 3958.31 Mio. EUR |
| 8369.47 Mio. EUR |
| 0.16 |
| 7.51% |
| 130.94% |
| 1.51 EUR |
| 3.26% |
| 3.26% |
| 20.02.26 - 0.412035€ 14.11.25 - 0.35848713€ >weitere anzeigen... |
| - |
| GSK ADR, GSK, GLAXOSMITHKLINE, GLAXO |
| 05.04.26 |
|